Conjugation of haloperidol to PEG allows peripheral localisation of haloperidol and eliminates CNS extrapyramidal effects

被引：0
|
作者：
Natfji, Az Alddien [1 ]
Nikitin, Dmitry O. [2 ]
Semina, Irina I. [2 ]
Moustafine, Rouslan I. [3 ]
Khutoryanskiy, Vitaliy V. [1 ,3 ]
Lin, Hong [1 ]
Stephens, Gary J. [1 ]
Watson, Kimberly A. [4 ]
Osborn, Helen M.I. [1 ]
Greco, Francesca [1 ]
机构：
[1] Reading School of Pharmacy, University of Reading, Whiteknights, Reading,RG6 6AD, United Kingdom
[2] Department of Pharmacology, Kazan State Medical University, 6/30 Tolstogo Street, Kazan,420012, Russia
[3] Institute of Pharmacy, Kazan State Medical University, 16 Fatykh Amirkhan Street, Kazan,420126, Russia
[4] Institute of Cardiovascular and Metabolic Research, School of Biological Sciences, University of Reading, Whiteknights, Berkshire,RG6 6AS, United Kingdom
来源：
Journal of Controlled Release | 2020年 / 322卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：227 / 235
相关论文
共 50 条
  • [21] RELATIONSHIPS BETWEEN SERUM LEVELS OF HALOPERIDOL AND PROLACTIN, ANTIPSYCHOTIC EFFECT, AND EXTRAPYRAMIDAL SIDE-EFFECTS
    MOLLER, HJ
    KISSLING, W
    MAURACH, R
    SCHMID, W
    DOERR, P
    PIRKE, K
    VONZERSSEN, D
    PHARMACOPSYCHIATRIA, 1981, 14 (01): : 27 - 34
  • [22] Symptom change and extrapyramidal side effects during acute haloperidol treatment in chronic geriatric schizophrenics
    Weisbard, JJ
    Pardo, M
    Pollack, S
    PSYCHOPHARMACOLOGY BULLETIN, 1997, 33 (01) : 119 - 122
  • [23] EXTRAPYRAMIDAL SIDE-EFFECTS OF PARKINSONIAN TYPE IN ACUTELY ILL SCHIZOPHRENICS, TREATED WITH REMOXIPRIDE OR HALOPERIDOL
    MARKLUND, M
    BLOMQVIST, M
    LEWANDER, T
    PSYCHOPHARMACOLOGY, 1991, 103 (04) : B10 - B10
  • [24] Effects of subchronic administration of clozapine, thioridazine and haloperidol on tests related to extrapyramidal motor function in the rat
    Trevitt, J
    Atherton, A
    Aberman, J
    Salamone, JD
    PSYCHOPHARMACOLOGY, 1998, 137 (01) : 61 - 66
  • [25] Extrapyramidal side effects with risperidone and haloperidol at comparable D2 receptor occupancy levels
    Knable, MB
    Heinz, A
    Raedler, T
    Weinberger, DR
    PSYCHIATRY RESEARCH-NEUROIMAGING, 1997, 75 (02) : 91 - 101
  • [26] INHIBITION OF EXTRAPYRAMIDAL SIDE-EFFECTS OF HALOPERIDOL THROUGH JOINT USE OF IMIPRAMINE-TYPE DRUGS
    BUTTERWORTH, AT
    PSYCHOSOMATICS, 1972, 13 (05) : 328 - 332
  • [27] Interplay between adenosine receptor antagonist and cyclooxygenase inhibitor in haloperidol-induced extrapyramidal effects in mice
    Devinder Arora
    Jayesh Mudgal
    Madhavan Nampoothiri
    Sanchari Basu Mallik
    Manas Kinra
    Susan Hall
    Shailendra Anoopkumar-Dukie
    Gary D. Grant
    Chamallamudi Mallikarjuna Rao
    Metabolic Brain Disease, 2018, 33 : 1045 - 1051
  • [28] Interplay between adenosine receptor antagonist and cyclooxygenase inhibitor in haloperidol-induced extrapyramidal effects in mice
    Arora, Devinder
    Mudgal, Jayesh
    Nampoothiri, Madhavan
    Mallik, Sanchari Basu
    Kinra, Manas
    Hall, Susan
    Anoopkumar-Dukie, Shailendra
    Grant, Gary D.
    Rao, Chamallamudi Mallikarjuna
    METABOLIC BRAIN DISEASE, 2018, 33 (04) : 1045 - 1051
  • [29] Combined treatment of quetiapine with haloperidol in animal models of antipsychotic effect and extrapyramidal side effects: comparison with risperidone and chlorpromazine
    Miho Tada
    Kiyoharu Shirakawa
    Nobuya Matsuoka
    Seitaro Mutoh
    Psychopharmacology, 2004, 176 : 94 - 100
  • [30] Effects of a novel neurotensin peptide analog given extracranially on CNS behaviors mediated by apomorphine and haloperidol
    Cusack, B
    Boules, M
    Tyler, BM
    Fauq, A
    McCormick, DJ
    Richelson, E
    BRAIN RESEARCH, 2000, 856 (1-2) : 48 - 54
12345